Tyrosine residues at the substrate binding site in human NQO1 homodimer: Protein conformational dynamics and

Maribel Rivero1,2, Juan Luis Pacheco-Garcia3, Pavla Vankova4

  • 1Department of Biochemistry and Molecular and Cellular Biology, Faculty of Sciences, University of Zaragoza, Zaragoza, Spain.

The FEBS Journal
|March 25, 2026
PubMed

Insights

Human NQO1 enzyme

Area of Science:

  • Biochemistry
  • Enzymology
  • Structural Biology

Background:

  • Human NAD(P)H:quinone oxidoreductase 1 (NQO1) is a crucial flavoenzyme involved in redox metabolism.
  • NQO1 plays a role in diseases like cancer and Alzheimer's.
  • Specific residues, Tyr126 and Tyr128, in the substrate binding site are hypothesized to regulate NQO1's catalytic activity.

Purpose of the Study:

  • To investigate the functional roles of Tyr126 and Tyr128 in human NQO1.
  • To elucidate how these residues impact enzyme dynamics, substrate binding, and catalytic efficiency.

Main Methods:

  • Generation of point mutants at Tyr126 and Tyr128 positions.
  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to assess protein dynamics.
  • Rapid-mixing pre-steady-state kinetics to measure hydride transfer (HT) efficiency and enzyme turnover.

Main Results:

  • Mutations at Tyr126 and Tyr128 significantly disrupted enzyme dynamics, affecting both the substrate binding site and inter-active site communication.
  • Mutations to Ala and Glu at these positions markedly reduced hydride transfer efficiency.
  • All variants showed impaired enzyme turnover and altered substrate specificity towards quinones.

Conclusions:

  • Tyr126 and Tyr128 are critical for optimizing substrate binding geometry and overall enzyme conformational dynamics in NQO1.
  • These residues are essential for the efficient asymmetric catalytic cycle of the NQO1 homodimer.
  • The findings provide insights into NQO1's mechanism and its implications in disease.

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.3K
Conserved Binding Sites01:49

Conserved Binding Sites

2.0K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.1K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.4K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.8K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

3.2K